Covered recipient · General Payments record
BRANDON CHAU LAM
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2023–2024
$1,425.68
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $862.86 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $260.41 | 3 |
| Regeneron Pharmaceuticals, Inc. | $200.14 | 2 |
| Tarsus Pharmaceuticals, Inc. | $142.86 | 1 |
| Sight Sciences, Inc. | $139.21 | 1 |
| Genentech USA, Inc. | $120.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alcon Vision LLC | $19.77 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082477557 | CMS |
| Alcon Vision LLC | $125.18 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082477561 | CMS |
| Alcon Vision LLC | $115.46 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082477559 | CMS |
| Genentech USA, Inc. | $120.24 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132982203 | CMS |
| Regeneron Pharmaceuticals, Inc. | $149.92 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114401435 | CMS |
| Regeneron Pharmaceuticals, Inc. | $50.22 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114401437 | CMS |
| Sight Sciences, Inc. | $139.21 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151923918 | CMS |
| Tarsus Pharmaceuticals, Inc. | $142.86 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139110313 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.